Tagamet
NDC 63029-222, Cimetidine, tablet, from Medtech Products Inc..
- Product NDC
- 63029-222
- Status
- Listed
- Labeler
- Medtech Products Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA020238
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63029-222 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CIMETIDINE200 mg/1
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63029-222-01 | 63029022201 | 1 BLISTER PACK in 1 BOX (63029-222-01) / 30 TABLET in 1 BLISTER PACK |
| 63029-222-02 | 63029022202 | 1 BLISTER PACK in 1 BOX (63029-222-02) / 6 TABLET in 1 BLISTER PACK |
| 63029-222-03 | 63029022203 | 1 BLISTER PACK in 1 BOX (63029-222-03) / 50 TABLET in 1 BLISTER PACK |
| 63029-222-04 | 63029022204 | 4 BLISTER PACK in 1 BOX (63029-222-04) / 10 TABLET in 1 BLISTER PACK |
| 63029-222-05 | 63029022205 | 4 BLISTER PACK in 1 BOX (63029-222-05) / 9 TABLET in 1 BLISTER PACK |
| 63029-222-06 | 63029022206 | 7 BLISTER PACK in 1 BOX (63029-222-06) / 10 TABLET in 1 BLISTER PACK |
| 63029-222-09 | 63029022209 | 1 BOTTLE in 1 CARTON (63029-222-09) / 90 TABLET in 1 BOTTLE |
| 63029-222-11 | 63029022211 | 1 BOTTLE in 1 CARTON (63029-222-11) / 100 TABLET in 1 BOTTLE |
| 63029-222-12 | 63029022212 | 2 BLISTER PACK in 1 BOX (63029-222-12) / 6 TABLET in 1 BLISTER PACK |
| 63029-222-70 | 63029022270 | 1 BOTTLE in 1 CARTON (63029-222-70) / 70 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63029-222 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63029-222 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63029-222. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.